A Randomized, Multicenter, International, Open-Label Study of Infliximab Plus Methotrexate Versus Methotrexate (MTX) Alone for the Treatment of MT naïve Subjects With Active Psoriatic Arthritis.
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Infliximab (Primary) ; Methotrexate
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms RESPOND
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 12 Oct 2011 Results published in full in the Annals of the Rheumatic Diseases.
- 21 Oct 2009 Results presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology.
- 17 Nov 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History